Urinary Stone

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Avvio Medical
Avvio MedicalCA - San Francisco
2 programs
Enhanced Lithotripsy SystemN/A1 trial
Enhanced Lithotripsy SystemN/A1 trial
Active Trials
NCT03339388TerminatedEst. Oct 2022
NCT03195920TerminatedEst. Oct 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Avvio MedicalEnhanced Lithotripsy System
Avvio MedicalEnhanced Lithotripsy System

Clinical Trials (2)

NCT03339388Avvio MedicalEnhanced Lithotripsy System

Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stone Disease

Start: Dec 2017Est. completion: Oct 2022
N/ATerminated
NCT03195920Avvio MedicalEnhanced Lithotripsy System

Feasibility Study of an Enhanced Lithotripsy System in the Treatment of Urinary Stone Disease

Start: Jul 2017Est. completion: Oct 2022
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space